N	Concordance
1	um-containing chemotherapy given as  adjuvant therapy directly after surger
2	tively, before radiation therapy, as adjuvant therapy after    surgery, or 
3	al comparing tamoxifen to placebo as adjuvant therapy for women with node n
4	ortant in the last few years as both adjuvant therapy and       treatment f
5	  - Dose-dense paclitaxel-containing adjuvant therapy for breast cancer. SO
6	l plus       levamisole as effective adjuvant therapy after resection of st
7	  as indicators of outcome following adjuvant therapy for breast cancer.   
8	  unethical after other trials found adjuvant therapy beneficial. A data  m
9	fluorouracil (CMF) vs doxorubicin in adjuvant therapy and in metastatic dis
10	lso broad agreement about the use of adjuvant therapy and radical       res
11	hould routinely receive some form of adjuvant therapy after completion of l
12	- Influence of surgical resection on adjuvant therapy and outcome [letter] 
13	   Prior fluorouracil-based or other adjuvant therapy allowed       At leas
14	nical trials, postoperative systemic adjuvant therapy for breast cancer sug
15	  "resistance" of malignant cells to adjuvant therapy caused by       inade
16	es for the administration of topical adjuvant therapy after       endoscopi